产品编号：D528810
产品规格：2.5mg
产品价格：面议
| 标准品编号: | D528810 |
| 名称: | Dolutegravir O-β-D-Glucuronide |
| 别名: | (4R,12aS)-9-[[[(2,4-Difluorophenyl)methyl]amino]carbonyl]-3,4,6,8,12,12a-hexahydro-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-yl β-D-Glucopyranosiduronic Acid |
| CAS号: | 1485692-21-4 |
| 分子式: | C₂₆H₂₇F₂N₃O₁₁ |
| 外观: | 白色固体 |
| 熔点: | 122-124°C |
| 分子量: | 595.5 |
| 储存: | Hygroscopic, -20°C Freezer, Under inert atmosphere |
| 溶解度: | Methanol (Very Slightly), Water (Slightly) |
| 种类: | Standards; Chiral Molecules; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | Dolutegravir O-β-D-Glucuronide is a metabolite of Dolutegravir (D528800); a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4 cells infected with a self-inactivating PHIV lentiviral vector. |
| 参考文献 | |
